NCT03945513 — "A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles" trial site landscape

Public-registry site landscape for NCT03945513, “A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles”, a Contraception study sponsored by Insud Pharma. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03945513 (registry record)
Study title	A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
Official title	A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424 (Dienogest 2 mg / Ethinyl Estradiol 0.02 mg) During 13 Cycles
Sponsor	Insud Pharma
Condition(s)	Contraception
Phase	PHASE3
Listed sites	1
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT03945513.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03945513 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →